| Real-world five-year outcomes of FlexyRap? cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease |
| |
| 引用本文： | Nitish Garg,Raman Chawla,Vivek Tandon,Deepak Garg,Nilesh Parshottam,Preeti Vani,Malte Neuss. Real-world five-year outcomes of FlexyRap? cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease[J]. World journal of cardiology, 2023, 15(3): 84-94. DOI: doi:10.4330/wjc.v15.i3.84 |
| |
| 作者姓名： | Nitish Garg Raman Chawla Vivek Tandon Deepak Garg Nilesh Parshottam Preeti Vani Malte Neuss |
| |
| 摘 要： | BACKGROUND The use of biodegradable polymer drug-eluting stents(BP-DES) has been proven to minimize restenosis and stent thrombosis. The current post-marketing monitoring was observed at the 5-year clinical outcomes of individuals who had been treated with FlexyRap? DES in the real world.AIM To assess the safety and effectiveness of FlexyRap? DES at the 5-year follow-up in real-world settings.METHODS Findings from a retrospective, multi-center, observational, post-market cl...
|
Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease |
| |
| Nitish Garg,Raman Chawla,Vivek Tandon,Deepak Garg,Nilesh Parshottam,Preeti Vani,Malte Neuss. Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease[J]. World journal of cardiology, 2023, 15(3): 84-94. DOI: doi:10.4330/wjc.v15.i3.84 |
| |
| Authors: | Nitish Garg Raman Chawla Vivek Tandon Deepak Garg Nilesh Parshottam Preeti Vani Malte Neuss |
| |
| Abstract: | |
| |
| Keywords: | Coronary artery disease Drug-eluting stents Percutaneous coronary intervention Rapamycin Sirolimus |
|
| 点击此处可从《World journal of cardiology》浏览原始摘要信息 |
